AU5691999A - Use of fructose-1,6-diphosphate as an inotrope drug for cardiopulmonary bypass surgery - Google Patents

Use of fructose-1,6-diphosphate as an inotrope drug for cardiopulmonary bypass surgery

Info

Publication number
AU5691999A
AU5691999A AU56919/99A AU5691999A AU5691999A AU 5691999 A AU5691999 A AU 5691999A AU 56919/99 A AU56919/99 A AU 56919/99A AU 5691999 A AU5691999 A AU 5691999A AU 5691999 A AU5691999 A AU 5691999A
Authority
AU
Australia
Prior art keywords
diphosphate
fructose
cardiopulmonary bypass
bypass surgery
inotrope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56919/99A
Inventor
Anthony W. Fox
Paul J. Marangos
Angel K. Markov
Bernhard Riedel
David Royston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt ARD Inc
Original Assignee
Cypros Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cypros Pharmaceuticals Corp filed Critical Cypros Pharmaceuticals Corp
Publication of AU5691999A publication Critical patent/AU5691999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56919/99A 1999-08-30 1999-08-30 Use of fructose-1,6-diphosphate as an inotrope drug for cardiopulmonary bypass surgery Abandoned AU5691999A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/019432 WO2001015705A1 (en) 1999-08-30 1999-08-30 Use of fructose-1,6-diphosphate as an inotrope drug for cardiopulmonary bypass surgery

Publications (1)

Publication Number Publication Date
AU5691999A true AU5691999A (en) 2001-03-26

Family

ID=22273460

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56919/99A Abandoned AU5691999A (en) 1999-08-30 1999-08-30 Use of fructose-1,6-diphosphate as an inotrope drug for cardiopulmonary bypass surgery

Country Status (2)

Country Link
AU (1) AU5691999A (en)
WO (1) WO2001015705A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006016904A2 (en) * 2004-04-14 2006-02-16 Uab Research Foundation Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1162443B (en) * 1979-01-16 1987-04-01 Foscama Biomed Chim Farma FERRIC SALT OF FRUCTOSE-1,6-DIPHOSPHATE PROCEDURE FOR ITS PRODUCTION AND ITS USE IN THE PREPARATION OF FRUCTOSE-1,6-DIPHOSPHORIC ACID
JPH05271269A (en) * 1992-03-27 1993-10-19 Unitika Ltd Purification of fructose-1,6-diphosphate
US5731291A (en) * 1996-05-08 1998-03-24 Cypros Pharmaceutical Corp. Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans

Also Published As

Publication number Publication date
WO2001015705A1 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
AU1924699A (en) Compounds of heteroaryl substituted imidazole, their pharmaceutical compositionsand uses
AU2002251958A1 (en) Surgical master/slave system
AU5143000A (en) Implantable medical device such as an anastomosis device
AU2002363329A1 (en) Pharmacogenomics-based system for clinical applications
AU6421300A (en) Workspace partition system
AU2002363005A1 (en) Derivatives of uk-2a
AU4607600A (en) Medical positioning system
AU5722800A (en) Imidazoline derivatives for the treatment of diabetes, especially type ii diabetes
AU2003247725A1 (en) Interferometer system of compact configuration
AU3932999A (en) Pyrazoline derivatives, their preparation and application as medicaments
AU2177001A (en) Use of indirubine derivatives for making medicines
AUPQ137699A0 (en) Control of acidosis
AU4117400A (en) Medical instruments
AU5691999A (en) Use of fructose-1,6-diphosphate as an inotrope drug for cardiopulmonary bypass surgery
AU6866500A (en) Chromone derivatives, process for the preparation of the same and uses thereof
AU2002358469A1 (en) Modified receptors for the discovery of therapeutic ligands
AU5566400A (en) Process for the preparation of imidazole derivatives
AU2943400A (en) Process for the preparation of alpha-aminoketone derivatives
AUPP841199A0 (en) Control of mange
AU4303700A (en) 6-(((aryl and heteroaryl)oxy) methyl)naphthalene -2-carboximidamide derivatives,preparation and therapeutic application thereof
AU4450100A (en) 225Ac-heha and related compounds, methods of synthesis and methods of use
AU4685699A (en) Preparation of heteroaryl compounds
EP1304644A3 (en) System for checking of treatment plans
AU4961600A (en) Potentiation of chloroquine
AU2003293887A1 (en) Preparation of supported catalyst systems containing reduced amounts of aluminoxanes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase